Douglas Irwin, MD
Family Medicine · Manchester, KYNPI 1538115621
Payments from drug & device makers
Across 41 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$87
- Novartis$81
- Mylan Specialty L.p.$74
- AbbVie$56
- Portola Pharmaceuticals, LLC$44
- Merck$42
- plus $266 from 11 others
What the payments were for
- Food & beverage$650100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $87 |
| Novartis | 5 | $81 |
| Mylan Specialty L.p. | 3 | $74 |
| AbbVie | 3 | $56 |
| Portola Pharmaceuticals, LLC | 2 | $44 |
| Merck | 3 | $42 |
| AstraZeneca | 3 | $41 |
| Biomerieux Inc | 3 | $38 |
| GSK | 2 | $31 |
| Pfizer | 2 | $31 |
| Melinta Therapeutics, LLC | 2 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Philips North America LLC | 1 | $13 |
How this compares
$650 in reported general payments places this provider in the 45th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $12,141 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $362 |
| Quetiapine Fumarate | 15 | $336 |
| Bupropion Hcl SrBupropion Hcl | 13 | $171 |
| Atorvastatin Calcium | 12 | $145 |
| Levothyroxine Sodium | 11 | $142 |
| Rosuvastatin Calcium | 13 | $127 |
| Lisinopril | 22 | $104 |
| Doxycycline Monohydrate | 11 | $63 |
| Amlodipine Besylate | 15 | $61 |
| Hydrochlorothiazide | 11 | $36 |
| Metoprolol Tartrate | 11 | $30 |
| Tamsulosin Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Manchester
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.